Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Beckman Coulter Diagnostics and Seegene Supply Agreement
Monday, November 17, 2014
Supply agreement announced for multiplex reagents for VERIS molecular diagnostics system.

Roche Receives FDA Clearance for Strep A Test
Friday, November 14, 2014
The cobas Strep A test is the first molecular point of care test to provide a result in 15 minutes for this common infection.

Emergency Use Authorization for RealStar® Ebolavirus RT-PCR Kit 1.0 Granted
Friday, November 14, 2014
altona Diagnostics receives Emergency Use Authorization for RealStar® Ebolavirus RT-PCR Kit 1.0.

QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics
Thursday, November 13, 2014
Master collaboration agreement is a framework for developing and commercializing QIAGEN companion diagnostics, paired with new or existing products.

Horizon Discovery Group plc Establishes Scientific Advisory Board for Horizon Diagnostics Business Unit
Tuesday, November 11, 2014
The Scientific Advisory Board will recommend improvements needed in laboratories adopting Companion Diagnostic assays.

RainDance Appoints Martin M. Coyne II and Glenn P. Muir to Board of Directors
Friday, November 07, 2014
Executives bolster board expertise as Company expands its reach into leading genomics research labs by enabling non-invasive Fluid Biopsy™ applications.

InVentis Technologies to Distribute TriLink Products in India
Friday, November 07, 2014
InVentis Technologies will market TriLink’s complete line of nucleic acid-based products.

PositiveID Corporation Signs Agreement With U.S. Special Operations Command
Thursday, November 06, 2014
PositiveID enters cooperative research and development agreement with Special Operations Research, Development, & Acquisition Center, Science & Technology Directorate, for the continued development of the company's Firefly Dx System.

Clontech Licenses CRISPR/CAS9 Technology From Broad Institute
Tuesday, October 28, 2014
Clontech Laboratories, Inc. have entered into a non-exclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene editing system.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 652

SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv